Experimental cell therapy tested in advanced liver cancer patients
NCT ID NCT04756648
Summary
This is an early Phase 1 study to check the safety and find the right dose of an experimental cell therapy called CT0180 for people with advanced liver cancer. The study will enroll 21 patients who have already tried other treatments. Researchers will give patients one or more infusions of these specially engineered cells and closely monitor for side effects and any early signs that the treatment might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First affiliated hospital, Zhejiang University
Hangzhou, Zhejiang, 310006, China
Conditions
Explore the condition pages connected to this study.